| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461968037P | 2014-03-20 | 2014-03-20 |
| Publication Number | Publication Date |
|---|---|
| PT3119384Ttrue PT3119384T (pt) | 2018-12-12 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT15714132TPT3119384T (pt) | 2014-03-20 | 2015-03-19 | Tratamento de doenças colestáticas intra-hepáticas |
| Country | Link |
|---|---|
| US (5) | US9486428B2 (pt) |
| EP (1) | EP3119384B1 (pt) |
| JP (1) | JP6568577B2 (pt) |
| KR (1) | KR102000332B1 (pt) |
| CN (1) | CN106102734B (pt) |
| AU (1) | AU2015231232B2 (pt) |
| BR (1) | BR112016020260A8 (pt) |
| CA (1) | CA2941401C (pt) |
| CL (1) | CL2016002338A1 (pt) |
| CY (1) | CY1120927T1 (pt) |
| DK (1) | DK3119384T3 (pt) |
| EA (1) | EA032358B1 (pt) |
| ES (1) | ES2701094T3 (pt) |
| FI (1) | FIC20253004I1 (pt) |
| FR (1) | FR25C1031I1 (pt) |
| HR (1) | HRP20181914T1 (pt) |
| HU (2) | HUE041733T2 (pt) |
| IL (1) | IL247920B (pt) |
| LT (2) | LT3119384T (pt) |
| MX (1) | MX367478B (pt) |
| NL (1) | NL301338I2 (pt) |
| NO (1) | NO2025035I1 (pt) |
| NZ (1) | NZ724057A (pt) |
| PH (1) | PH12016501769B1 (pt) |
| PL (1) | PL3119384T3 (pt) |
| PT (1) | PT3119384T (pt) |
| RS (1) | RS57970B1 (pt) |
| SI (1) | SI3119384T1 (pt) |
| SM (1) | SMT201800690T1 (pt) |
| UA (1) | UA120756C2 (pt) |
| WO (1) | WO2015143178A1 (pt) |
| ZA (1) | ZA201606043B (pt) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011004077A (es) | 2008-10-17 | 2011-08-17 | Metabolex Inc | Metodos para reducir particulas de ldl densas, pequeñas. |
| US10272058B2 (en) | 2014-03-20 | 2019-04-30 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| JP6865038B2 (ja) | 2014-04-11 | 2021-04-28 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Ｎａｆｌｄおよびｎａｓｈの治療 |
| US10512622B2 (en) | 2017-07-14 | 2019-12-24 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| RS62790B1 (sr)* | 2017-09-26 | 2022-02-28 | Cymabay Therapeutics Inc | Tretman holestatskog pruritusa sa seladelparom |
| MX2021005725A (es)* | 2018-11-16 | 2021-07-21 | Cymabay Therapeutics Inc | Tratamiento de la obesidad y sus complicaciones. |
| CA3148602A1 (en) | 2019-08-02 | 2021-02-11 | Acelot, Inc. | Small molecule drugs and related methods for treatment of diseases related to tdp-43, alpha-synuclein, huntingtin's protein and tau protein oligomer formation |
| US20210145774A1 (en) | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Treatment of alcoholic liver disease |
| WO2021097034A1 (en) | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Seladelpar for use in the treatment of intestinal barrier dysfunction and associated diseases |
| EP4225291B1 (en) | 2021-02-01 | 2024-03-13 | CymaBay Therapeutics, Inc. | Treatment of cholangiopathies with seladelpar |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7101993B1 (en) | 1990-01-11 | 2006-09-05 | Isis Pharmaceuticals, Inc. | Oligonucleotides containing 2′-O-modified purines |
| US7015315B1 (en) | 1991-12-24 | 2006-03-21 | Isis Pharmaceuticals, Inc. | Gapped oligonucleotides |
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| JPH10512894A (ja) | 1995-03-06 | 1998-12-08 | アイシス・ファーマシューティカルス・インコーポレーテッド | ２’−ｏ−置換ピリミジンおよびそのオリゴマー化合物の合成の改良法 |
| US6166197A (en) | 1995-03-06 | 2000-12-26 | Isis Pharmaceuticals, Inc. | Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions |
| CZ243498A3 (cs) | 1996-02-14 | 1999-09-15 | Isis Pharmaceuticals, Inc. | Oligonukleotidy s mezerou a modifikovaným cukrem |
| US5883109A (en) | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
| US6066653A (en) | 1997-01-17 | 2000-05-23 | Bristol-Myers Squibb Co. | Method of treating acid lipase deficiency diseases with an MTP inhibitor and cholesterol lowering drugs |
| US7407943B2 (en) | 2001-08-01 | 2008-08-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein B expression |
| US7511131B2 (en) | 2002-11-13 | 2009-03-31 | Genzyme Corporation | Antisense modulation of apolipoprotein B expression |
| US7981915B2 (en)* | 2003-04-30 | 2011-07-19 | Beth Israel Deaconess Medical Center | Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene |
| CN1882533B (zh) | 2003-09-19 | 2010-06-09 | 詹森药业有限公司 | 4-((苯氧基烷基)硫基)-苯氧基乙酸及其类似物 |
| CA2558766A1 (en) | 2004-03-05 | 2005-09-22 | The Trustees Of The University Of Pennsylvania | The use of mtp inhibitors for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects |
| JO3006B1 (ar)* | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| MX2011004077A (es) | 2008-10-17 | 2011-08-17 | Metabolex Inc | Metodos para reducir particulas de ldl densas, pequeñas. |
| ES2586127T3 (es) | 2010-03-30 | 2016-10-11 | Novartis Ag | Usos de inhibidores de DGAT1 |
| JOP20200043A1 (ar) | 2011-05-10 | 2017-06-16 | Amgen Inc | طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول |
| US20160279085A1 (en) | 2013-11-20 | 2016-09-29 | Cymabay Therapeutics, Inc. | Treatment of Severe Hyperlipidemia |
| HK1224186A1 (zh) | 2013-11-20 | 2017-08-18 | Cymabay Therapeutics, Inc. | 纯阖家族型高胆固醇血症的治疗 |
| US10272058B2 (en) | 2014-03-20 | 2019-04-30 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| JP6865038B2 (ja) | 2014-04-11 | 2021-04-28 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Ｎａｆｌｄおよびｎａｓｈの治療 |
| SG11201610243YA (en) | 2014-06-26 | 2017-01-27 | Cymabay Therapeutics Inc | Treatment of severe hypertriglyceridemia |
| US10512622B2 (en) | 2017-07-14 | 2019-12-24 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| RS62790B1 (sr) | 2017-09-26 | 2022-02-28 | Cymabay Therapeutics Inc | Tretman holestatskog pruritusa sa seladelparom |
| MX2021005725A (es) | 2018-11-16 | 2021-07-21 | Cymabay Therapeutics Inc | Tratamiento de la obesidad y sus complicaciones. |
| KR20210092754A (ko) | 2018-11-16 | 2021-07-26 | 사이머베이 쎄라퓨틱스, 인코퍼레이티드 | Nafld 및 nash의 병용 치료 |
| Publication | Publication Date | Title |
|---|---|---|
| ZA201807084B (en) | Methods of treatment of cholestatic diseases | |
| HUS2500033I1 (hu) | Intrahepatikus kolesztázisos betegségek kezelése | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| PL3283527T3 (pl) | Leczenie skojarzone nowotworów | |
| DK3851537T5 (da) | Behandling af hyperbilirubinæmi | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3450553T3 (da) | Mrna-terapi til behandling af øjensygdomme | |
| IL252096A0 (en) | Microneedle arrays for cancer therapy applications | |
| DK3097085T3 (da) | Benzoxazinonderivater til behandling af hudsygdomme | |
| DK3132009T3 (da) | Fremgangsmåde | |
| IL257764B (en) | Methods for treatment of diseases | |
| DK3164394T3 (da) | Gls1-inhibitorer til behandling af sygdomme | |
| EP3356516A4 (en) | CULTIVATION OF HUMAN NOROVIRES | |
| DK3374495T3 (da) | Forbedrede fremgangsmåder til vævsfremstilling | |
| ZA201808360B (en) | Treatment of intrahepatic cholestatic diseases | |
| EP3337474A4 (en) | QUANTITATIVE PERIORBITAL APPLICATION OF EYE DISORDER | |
| FR3022129B1 (fr) | Baignoire de puericulture | |
| FR3024647B1 (fr) | Transat de puericulture | |
| IL253847A0 (en) | Methods of treating diseases | |
| DK3182980T3 (da) | Behandling af glykosyleringsmangelsygdomme | |
| HUE063820T2 (hu) | Módszerek kardiovaszkuláris betegségek kezelésére | |
| DK3200783T3 (da) | Behandling af erytromelalgi | |
| GB201410407D0 (en) | Treatment of chagas disease | |
| SI3302499T1 (sl) | Zdravljenje mitohondrijskih bolezni | |
| EP3313519A4 (en) | TREATMENT OF MYOPATHY |